Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study
The Journal of Clinical Endocrinology & Metabolism · 18.12.2025 · 111 (1) · e148-e155
DOI: 10.1210/clinem/dgaf319 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 29.05.2025. Verfasst von Richard C Frank und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology/Oncology, Nuvance Health, Norwalk, CT 06856, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Early Detection of Cancer, Diabetes Mellitus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tribute to Pamela/The Naughton Family Fund, Rallye for Pancreatic Cancer, Glenn W. Bailey Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Pancreatic cancer (PC) has a high mortality rate due to the lack of early-stage detection strategies and lethality of advanced stage presentations. New-onset diabetes (NOD) in individuals ≥50 years old increases the risk 6- to 8-fold, making this group a target of early detection studies. There is also evidence that deteriorating diabetes (DD) may be a risk factor. Research design and methods The study prospectively enrolled individuals ≥50 years with NOD or DD. Participants underwent magnetic resonance imaging/cholangiopancreatography, blood biobanking and anxiety/depression monitoring. Magnetic resonance imaging scans were scored as normal, benign-abnormal, suspicious, or incidental finding. Glycemic indices and physician referral patterns were captured.
Results
Over a 6-year period, 625 individuals were screened and 109 enrolled, 97 (89%) had NOD, and 12 (11%) had DD. Compared to the NOD cohort, the DD cohort was older, had higher hemoglobin A1c levels (P = .02), greater weight loss (P = .0038), and insulin requirements (P < .0001). Four pancreas biopsies were performed for suspicious findings (3.6%), with a stage 1 pancreatic ductal adenocarcinoma identified in the DD group, corresponding to an overall detection rate of 0.9% (1/109). The detection rates of benign pancreatic abnormalities and incidental findings revealed no safety signals. Endocrinologists were the main referral source for the DD cohort (P < .001).
Conclusion
Results from the PANDOME study thus far include the first reported screen-detected early-stage PC in a sporadic cohort. Our findings support the inclusion of a DD cohort in prospective PC screening studies in high-risk diabetes. Endocrinologists play an especially important role in the referral of individuals with DD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Hematology/Oncology, Nuvance Health, Norwalk, CT 06856, USA.
- Department of Radiology, Nuvance Health, Danbury, CT 06810, USA.
- Department of Research & Innovation, Nuvance Health, Danbury, CT 06810, USA.
- Department of Surgery, Nuvance Health, Danbury, CT 06810, USA.
- Department of Medicine, Nuvance Health, Norwalk, CT 06856, USA.
- Department of Gastroenterology, Nuvance Health, Norwalk, CT 06856, USA.
ORCID-Profile: Richard C Frank
Förderung
- Tribute to Pamela/The Naughton Family Fund
- Rallye for Pancreatic Cancer
- Glenn W. Bailey Foundation
Zitieren
APA
Frank, R. C., Shim, B., Lo, T., Pandya, D., Krebs, T. L., Ma, C., Labow, D., Denowitz, J., Anand, N., Krumholtz, P., Sullivan, K., Sanchez, M., Dong, X. E., Seshadri, R., Trinidad, A., & Jin, D. (2025). Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study. The Journal of Clinical Endocrinology & Metabolism, 111(1), e148-e155. https://doi.org/10.1210/clinem/dgaf319
Vancouver
Frank RC, Shim B, Lo T, Pandya D, Krebs TL, Ma C, et al. Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study. The Journal of Clinical Endocrinology & Metabolism. 2025;111(1):e148-e155. doi:10.1210/clinem/dgaf319
BibTeX
@article{Frank2025,
author = {Frank, Richard C and Shim, Brian and Lo, Tammy and Pandya, Deep and Krebs, Thorsten L and Ma, Charles and Labow, Daniel and Denowitz, Jill and Anand, Naveen and Krumholtz, Pramila and Sullivan, Kiyoe and Sanchez, Mark and Dong, Xiang Eric and Seshadri, Ramanathan and Trinidad, Antolin and Jin, Dugho},
title = {Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {111},
number = {1},
pages = {e148--e155},
doi = {10.1210/clinem/dgaf319}
}
EUVIMED